PARVB and breast neoplasm: Specifically, gene expression analysis at the mRNA level demonstrated a significant downregulation of PARVB in four (4) out of nine (9) human breast tumors compared to their patient-matched normal mammary gland tissue, while a dramatic downregulation was also observed at the protein level in five (5) out of seven (7) advanced tumors [43].